Kimberly-Clark's Acquisition of Kenvue Faces Uncertainty Amid Weakening Sales and Legal Concerns.

jueves, 6 de noviembre de 2025, 3:20 am ET1 min de lectura
KMB--
KVUE--

Kimberly-Clark's stock fell 1.7% to $100.55 as investors questioned the company's decision to acquire Kenvue, which has weakening sales and potential legal liabilities related to Tylenol and talc. The deal requires shareholder approval from both companies.

Kimberly-Clark's Acquisition of Kenvue Faces Uncertainty Amid Weakening Sales and Legal Concerns.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios